Mitochondria Could Be a Target for Therapeutic Strategy for Alzheimer’s Disease

A study in the Sept. 21 on-line edition of Nature Medicine describes the function and interaction of a critical molecule involved in cell death in Alzheimer’s disease patients. These new findings reveal that blocking this molecule, called Cyclophilin D (CypD), and development of surrounding mitochondrial targets may be viable therapeutic strategies for the prevention and treatment of Alzheimer’s disease. read more

Read the whole article on Science Blog

More from Science Blog